Cosmos Health Inc (COSM)

01:02 AM

Cosmos Health projects Cur18 to generate $2.5M in U.S. revenue - Investing.com Canada

01:02 AM

12:51 PM

Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months - Weatherford Democrat

12:51 PM

12:50 PM

A turmeric supplement is central to Cosmos Health's $2.5M U.S. sales bet - Stock Titan

12:50 PM

Apr 28, 2026

Cosmos Health (COSM) price target increased by 50.00% to 4.59 - MSN

Apr 28, 2026

Apr 25, 2026

Cosmos Health Continues US Expansion with Q2 Launch of Cur18a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health - ACCESS Newswire

Apr 25, 2026

Apr 24, 2026

Cosmos Health (COSM) holder reports 4.14M shares, 8.15% stake in amendment - Stock Titan

Apr 24, 2026

Apr 24, 2026

Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Produ - Palestineherald.com

Apr 24, 2026

Apr 24, 2026

73.5M Cosmos Health shares registered for resale (NASDAQ: COSM) - Stock Titan

Apr 24, 2026

Apr 23, 2026

Cosmos Health (COSM) Year-Ahead Outlook | Q4 2025: Below ExpectationsAcquisition - Xã Vĩnh Công

Apr 23, 2026

Apr 22, 2026

Is Cosmos Health (COSM) stock still a good play today | Q4 2025: Profit DisappointsReal-time Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026

Apr 22, 2026

Cosmos Health (COSM) Stock: Consolidation Phase Insight (Smart Money Flows) 2026-04-22Quantitative Analysis - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026

Apr 22, 2026

COSM Stock Price, Quote & Chart | COSMOS HEALTH INC (NASDAQ:COSM) - ChartMill

Apr 22, 2026

Apr 21, 2026

Cosmos Health Introduces the "18 Series" in the United StatesA Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products - Finviz

Apr 21, 2026

Apr 21, 2026

This supplement line only launches products at exact clinical-trial doses - Stock Titan

Apr 21, 2026

Apr 20, 2026

Cosmos Health to begin Liv18 liver supplement production in April By Investing.com - Investing.com Australia

Apr 20, 2026

Apr 20, 2026

COSM earnings show rapid revenue growth - MSN

Apr 20, 2026

Apr 20, 2026

Cosmos Health to begin Liv18 liver supplement production in April - Investing.com

Apr 20, 2026

Apr 20, 2026

A U.S.-made liver supplement is central to Cosmos Health's $5M push - Stock Titan

Apr 20, 2026

Apr 18, 2026

Cosmos Health (COSM) Unveils Innovative Curcumin Supplement for U.S. Market - GuruFocus

Apr 18, 2026

Apr 17, 2026

Cosmos Health expands AI integration across operations By Investing.com - Investing.com Australia

Apr 17, 2026

Apr 17, 2026

Cosmos Health plans Q2 U.S. launch of curcumin supplement By Investing.com - Investing.com Australia

Apr 17, 2026

Apr 17, 2026

Cosmos Health plans Q2 U.S. launch of curcumin supplement - Investing.com

Apr 17, 2026

Apr 17, 2026

A turmeric supplement with 39x absorption heads to the U.S. in Q2 - Stock Titan

Apr 17, 2026

Apr 17, 2026

Trending Industry Today: Cosmos Health Leads Gains In ETH-Holding Companies Stocks - Moomoo

Apr 17, 2026

Apr 17, 2026

Form 4Statement of changes in beneficial ownership of securities - ADVFN

Apr 17, 2026

Apr 16, 2026

Cosmos Health expands AI integration across operations - Investing.com

Apr 16, 2026

Apr 16, 2026

Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30% - ACCESS Newswire

Apr 16, 2026

Apr 16, 2026

Record 2025 revenue and margin expansion at Cosmos Health (COSM) - Stock Titan

Apr 16, 2026

Apr 15, 2026

Cosmos Health Inc. 2025 Annual Report: Growth Strategy, Product Portfolio, and Global Healthcare Market Expansion - Minichart

Apr 15, 2026

Apr 15, 2026

Cosmos Health (COSM) Achieves Record Revenue and Significant Mar - GuruFocus

Apr 15, 2026

Apr 15, 2026

Cosmos 2025 10-K: $65.3M Revenue, $(0.63) EPS on net loss - TradingView

Apr 15, 2026

Apr 15, 2026

Cosmos Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Apr 15, 2026

Apr 15, 2026

Cosmos Health (NASDAQ: COSM) expands pipeline, AI drug repurposing and equity funding - Stock Titan

Apr 15, 2026

Apr 15, 2026

Cosmos Health reports record revenue of $65.3 million in 2025 By Investing.com - Investing.com Australia

Apr 15, 2026

Apr 15, 2026

Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Con - ACCESS Newswire

Apr 15, 2026

Apr 15, 2026

Cosmos Health reports record revenue of $65.3 million in 2025 - Investing.com

Apr 15, 2026

Apr 14, 2026

Cosmos Health Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Apr 14, 2026

Apr 13, 2026

Cosmos Health receives third UAE order for 60,000 units By Investing.com - Investing.com Australia

Apr 13, 2026

Apr 13, 2026

Cosmos Health receives third UAE order for 60,000 units - Investing.com

Apr 13, 2026

Apr 13, 2026

Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units - ACCESS Newswire

Apr 13, 2026

Apr 13, 2026

A third UAE reorder lifts Cosmos Health product demand to 270,000 units - Stock Titan

Apr 13, 2026